Endocrinology

The American Society for Metabolic and Bariatric Surgery has released a new statement on the performing of metabolic and bariatric surgery during the COVID-19 pandemic.

In a recent cohort study, researcher examined the risk of serious renal events associated with the use of sodium-glucose co-transporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors.

In a recent study, researchers investigated the possibility of using grip strength tests in the screening of patients for type 2 diabetes mellitus.

The new safety labeling changes approved by the FDA address the use of SGLT2 inhibitors prior to surgery.

Findings from a retrospective new-user cohort study of female Medicare beneficiaries aged 65 years or older shed light on whether insulin glargine use is associated with increased breast cancer risk...

The US Preventive Services Task Force has released a new draft recommendation on screening for prediabetes and type 2 diabetes in adults.

The new treatment is the first FDA-approved drug to address the overproduction of cortisol in Cushing disease by blocking the enzyme known as 11-beta-hydroxylase and preventing cortisol synthesis.

Researchers aimed to determine whether target treatment to prevent new-onset atrial fibrillation was effective among patients with primary aldosteronism compared with controls with essential hypertension. ...

The new update accounts for a drug recently approved by the FDA and serves as a “formal amendment” to the 2019 guideline.

The US Food and Drug Administration has released laboratory results of metformin products tested for N-Nitrosodimethylamine.